Search by Drug Name or NDC

    NDC 82009-0026-10 AMLODIPINE BESYLATE 2.5 mg/1 Details

    AMLODIPINE BESYLATE 2.5 mg/1

    AMLODIPINE BESYLATE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Quallent Pharmaceuticals Health LLC. The primary component is AMLODIPINE BESYLATE.

    Product Information

    NDC 82009-0026
    Product ID 82009-026_7bd158b9-a62d-4b69-95ba-d026595836ac
    Associated GPIs
    GCN Sequence Number 016925
    GCN Sequence Number Description amlodipine besylate TABLET 2.5 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 02681
    HICL Sequence Number 006494
    HICL Sequence Number Description AMLODIPINE BESYLATE
    Brand/Generic Generic
    Proprietary Name AMLODIPINE BESYLATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name AMLODIPINE BESYLATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name AMLODIPINE BESYLATE
    Labeler Name Quallent Pharmaceuticals Health LLC
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077073
    Listing Certified Through 2024-12-31

    Package

    NDC 82009-0026-10 (82009002610)

    NDC Package Code 82009-026-10
    Billing NDC 82009002610
    Package 1000 TABLET in 1 BOTTLE (82009-026-10)
    Marketing Start Date 2023-12-15
    NDC Exclude Flag N
    Pricing Information N/A